Patent details

Basic Information

Publication number:

EP1945665

PCT Application Number:

PCT/US/2006/060113

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP068461201

PCT Publication Number:

WO/2007/048122

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTIBODY-BASED THERAPEUTICS WITH ENHANCED ADCC ACTIVITY

French Title of Invention:

THÉRAPIE À BASE D'ANTICORPS À ACTIVITÉ ADCC RENFORCÉE

German Title of Invention:

THERAPIEMITTEL AUF ANTIKÖRPERBASIS MIT ERHÖHTER ADCC-AKTIVITÄT

SPC Number:

Dates

Filing date:

20/10/2006

Grant date:

07/12/2011

EP Publication Date:

07/12/2011

PCT Publication Date:

26/04/2007

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/07/2008

EP B1 Publication Date:

07/12/2011

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

20/10/2019

Expiration date:

20/10/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/10/2006

 

 

Name:

GENZYME CORPORATION

Address:

500 Kendall Street, Cambridge, MA 02142, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

07/12/2011

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

MCPHERSON John, M.

Address:

United States (US)

2

Name:

EDMUNDS Tim

Address:

United States (US)

3

Name:

ZHOU Qun

Address:

United States (US)

Priority

Priority Number:

728947 P

Priority Date:

21/10/2005

Priority Country:

United States (US)

Classification

Main IPC Class:

C07K 16/00;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

09/10/2018

Last Annual Fee Paid Number:

13

Last Annual Fee Paid Amount:

180 Euro

Payer:

MARKS & CLERK LLP

Filing date	Document type	Number of pages